| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2023 ( Subtotal = $0 ) |
| | 2023 | 2022 | GLOBIN SOLUTIONS INC | 3710 FORBES AVE | PITTSBURGH | PA | 15213-3409 | ALLEGHENY | USA | R42ES031993 | Hemoglobin-based antidotes for the treatment of carbon monoxide poisoning | 000 | 3 | NIH | 4/11/2023 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $734,942 ) |
| | 2022 | 2022 | GLOBIN SOLUTIONS, INC. | 3710 FORBES AVE FL 3 | PITTSBURGH | PA | 15213-3409 | ALLEGHENY | USA | R42ES031993 | Hemoglobin-based antidotes for the treatment of carbon monoxide poisoning | 000 | 3 | NIH | 10/28/2021 | $734,942 |
|
| Issue Date FY: 2021 ( Subtotal = $748,895 ) |
| | 2021 | 2021 | GLOBIN SOLUTIONS, INC. | 3710 FORBES AVE FL 3 | PITTSBURGH | PA | 15213-3409 | ALLEGHENY | USA | R42ES031993 | Hemoglobin-based antidotes for the treatment of carbon monoxide poisoning | 000 | 2 | NIH | 11/4/2020 | $748,895 |
| | 2021 | 2020 | GLOBIN SOLUTIONS, INC. | 3710 FORBES AVE FL 3 | PITTSBURGH | PA | 15213-3409 | ALLEGHENY | USA | R42ES031993 | Hemoglobin-based antidotes for the treatment of carbon monoxide poisoning | 001 | 1 | NIH | 2/21/2021 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $249,993 ) |
| | 2020 | 2020 | GLOBIN SOLUTIONS, INC. | 3710 FORBES AVE FL 3 | PITTSBURGH | PA | 15213-3409 | ALLEGHENY | USA | R42ES031993 | Hemoglobin-based antidotes for the treatment of carbon monoxide poisoning | 000 | 1 | NIH | 1/31/2020 | $249,993 |
|
|
